Home » Bayer

Bayer

Dec 21, 2016

Bayer, Leica Biosystems Collaborate on CDx for Cancer Therapies

Companion diagnostics developed under the deal will be based on RNAscope and immunohistochemistry technology.

Jul 18, 2016

T2 Biosystems, Bayer Ink Hemostasis R&D Deal

The deal gives Bayer access to the T2 Magnetic Resonance technology for drug discovery and biomarker research in certain hemostasis programs.

May 17, 2016

Bayer Inks CRISPR Patent Licensing Agreement

The deal with ERS Genomics, a commercialization vehicle for Emmanuelle Charpentier's patents, gives the Bayer LifeScience Center access to CRISPR/Cas9 genome editing.

Mar 23, 2016

XCell Biosciences Aims to Improve CTC Analysis, Biomarker Discovery With New Cell Culture Platform

Premium

The company's Avatar platform cultures and propagates a variety of cell types in an in vivo-like environment to yield more accurate and relevant molecular analyses.

Dec 21, 2015

Bayer, CRISPR Therapeutics Launch JV to Develop CRISPR/Cas9 Treatments

The JV will be based in London with operations in Cambridge, Massachusetts and will develop new treatments for blood disorders, blindness, and congenital heart disease.

Mar 31, 2015

Bayer, Broad Expand Collaboration to Include Cardiovascular Genomics

The deal expands one reached in 2013 to discover and develop therapeutic agents targeting cancer genome alterations. 

Sep 05, 2014

MediSapiens Ramping Up US Operations, Developing Clinical Solution, Looking Beyond Oncology

Premium

NEW YORK (GenomeWeb) – Finland-based bioinformatics firm MediSapiens said this week that it is ramping up its US operations, including moving its East Cost subsidiary to a bigger office space in Cambridge, Mass., preparing to launch a new website, and planning to hire new staff, most likely in bu

May 16, 2014

Bayer Healthcare Taps MediSapiens' to Provide Genome Data Analysis, Storage

Premium

NEW YORK (GenomeWeb) – MediSapiens has announced that it will provide its software solution, dubbed the Integrated Genomics Platform, to Bayer Healthcare.

May 08, 2014

Cenix Inks Research Deal with Bayer

Premium

NEW YORK (GenomeWeb) – Cenix Biosciences this week announced that it has signed an agreement to provide RNAi-based high-content screening services to Germany's Bayer Pharma.

Apr 10, 2014

European Partners Pursue Lab-on-a-Chip System for Identifying Pancreatic Cancer CTCs

NEW YORK (GenomeWeb News) – A consortium of European research institutions and private partners will use €5.3 million ($7.4 million) in funding to develop a microfluidics-based lab-on-a-chip device to identify and measure the concentration of circulating tumor cells in blood, one of the partners,

Pages

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.